Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus Nephritis

Background/Aims. We aimed to examine the cost-effectiveness of mycophenolate mofetil (MMF) and azathioprine (AZA) as maintenance therapy for patients with Class III and Class IV lupus nephritis (LN), from a United States (US) perspective. Methods. Using a Markov model, we conducted a cost-utility an...

Full description

Bibliographic Details
Published in:	International Journal of Nephrology
Main Authors:	Robert Nee, Ian Rivera, Dustin J. Little, Christina M. Yuan, Kevin C. Abbott
Format:	Article
Language:	English
Published:	Wiley 2015-01-01
Online Access:	http://dx.doi.org/10.1155/2015/917567

Similar Items

LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis
by: Young Ho Lee, et al.
Published: (2023-07-01)

Off-lable uses of mycophenolate mofetil: lupus nephritis
by: B. Fernández-García, et al.
Published: (2015-07-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
by: Tomoo Kise, et al.
Published: (2015-01-01)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
by: Takashi Nawata, et al.
Published: (2017-01-01)

Mycophenolate mofetil vs. cyclophosphamide-based induction regimens for lupus nephritis: outcomes at a tertiary care centre in Lahore, Pakistan
by: Muhammad Ahmed Saeed, et al.
Published: (2024-04-01)

A Rare Case of Severe Skin Reaction to Mycophenolate Mofetil in Systemic Lupus Erythematosus with Lupus Nephritis
by: Rubiya M, et al.
Published: (2025-01-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
by: A. Hackl, et al.
Published: (2023-08-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

The Efficacy of Induction Treatment with a Cyclophosphamide- or Mycophenolate Mofetil-Based Regimen for Active Lupus Nephritis in Thailand: A Retrospective Cohort Study
by: Panuvich Poungsuwan, et al.
Published: (2025-02-01)

ANCA-Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab
by: Saika Sharmeen, et al.
Published: (2018-01-01)

Therapeutic drug monitoring of mycophenolate mofetil for the treatment of pediatric lupus nephritis: A cross-sectional study
by: Navamani Kirubakaran, et al.
Published: (2022-01-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Mycophenolate mofetil induced transfusion dependent anemia in lupus
by: Anand Prahalad Rao, et al.
Published: (2018-01-01)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
by: Xiaohui Zhang, et al.
Published: (2023-07-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01)

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab
by: Jing Zhou, et al.
Published: (2025-04-01)

Mycophenolate mofetil versus cyclophosphamide, in combination with prednisolone for lupus nephritis induction treatment: Findings from a prospective observational study
by: Rakhesh LR, et al.
Published: (2025-07-01)

WCN25-1843 MYCOPHENOLATE MOFETIL VS TACROLIMUS IN PURE CLASS V LUPUS NEPHRITIS – A RANDOMISED COMPARATIVE STUDY
by: Sanjana Sharma, et al.
Published: (2025-02-01)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01)

Steroid Refractory Immune Checkpoint Induced Acute Interstitial Nephritis Salvaged by Mycophenolate Mofetil
by: Prashanth Moku, et al.
Published: (2023-04-01)

Response to mycophenolate mofetil therapy in the patient with severe systemic lupus erythematosus
by: Božić-Majstorović Ljubinka, et al.
Published: (2016-01-01)

Mycophenolate mofetil versus azathioprine as a first-line treatment for autoimmune hepatitis: a comparative systematic review and meta-analysis
by: Amani M. Ali, et al.
Published: (2025-08-01)

A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors
by: Puneet Arora, et al.
Published: (2024-12-01)

LSO-026 Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: results from a real-world CSTAR cohort study
by: Wei Bai, et al.
Published: (2023-07-01)

Mycophenolate Mofetil-Induced Pneumatosis Intestinalis
by: Daphne Moutsoglou, et al.
Published: (2024-01-01)

Mycophenolate mofetil in giant cell arteritis
by: Anne Pankow, et al.
Published: (2023-11-01)

Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
by: Siqin Sun, et al.
Published: (2024-12-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Safety of mycophenolate mofetil in systemic lupus erythematosus maintenance therapy: insights from the LUNA registry in a nationwide prospective cohort study
by: Ken-ei Sada, et al.
Published: (2025-07-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
by: Rebecca M. Yim, et al.
Published: (2023-03-01)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
by: Joyce J. Kim, et al.
Published: (2020-01-01)

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
by: Seung Woon Park, et al.
Published: (2016-06-01)